Naturally Processed Non-canonical HLA-A*02:01 Presented Peptides

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2014 Dec 16

PMID 25505266

Citations 42

Authors

Chopie Hassan

Eric Chabrol

Lorenz Jahn

Michel G D Kester

Arnoud H de Ru

Jan W Drijfhout

Jamie Rossjohn

J H Frederik Falkenburg

Mirjam H M Heemskerk

Stephanie Gras

Peter A Van Veelen

Affiliations

Soon will be listed here.

Abstract

Human leukocyte antigen (HLA) class I molecules generally present peptides (p) of 8 to 11 amino acids (aa) in length. Although an increasing number of examples with lengthy (>11 aa) peptides, presented mostly by HLA-B alleles, have been reported. Here we characterize HLA-A*02:01 restricted, in addition to the HLA-B*0702 and HLA-B*4402 restricted, lengthy peptides (>11 aa) arising from the B-cell ligandome. We analyzed a number of 15-mer peptides presented by HLA-A*02:01, and confirmed pHLA-I formation by HLA folding and thermal stability assays. Surprisingly the binding affinity and stability of the 15-mer epitopes in complex with HLA-A*02:01 were comparable with the values observed for canonical length (8 to 11 aa) HLA-A*02:01-restricted peptides. We solved the structures of two 15-mer epitopes in complex with HLA-A*02:01, within which the peptides adopted distinct super-bulged conformations. Moreover, we demonstrate that T-cells can recognize the 15-mer peptides in the context of HLA-A*02:01, indicating that these 15-mer peptides represent immunogenic ligands. Collectively, our data expand our understanding of longer epitopes in the context of HLA-I, highlighting that they are not limited to the HLA-B family, but can bind the ubiquitous HLA-A*02:01 molecule, and play an important role in T-cell immunity.

Citing Articles

A nonadjuvanted HLA-restricted peptide vaccine induced both T and B cell immunity against SARS-CoV-2 spike protein.

Lee Y, Liou C, Liu I, Chang J Sci Rep. 2024; 14(1):20579.

PMID: 39242614 PMC: 11379847. DOI: 10.1038/s41598-024-71663-1.

Unconventional modes of peptide-HLA-I presentation change the rules of TCR engagement.

Hopkins J, MacLachlan B, Harper S, Sewell A, Cole D Discov Immunol. 2024; 1(1):kyac001.

PMID: 38566908 PMC: 10917088. DOI: 10.1093/discim/kyac001.

Designing a multi-epitope vaccine against based on an immunoinformatics approach.

Mao Y, Xiao X, Zhang J, Mou X, Zhao W Synth Syst Biotechnol. 2023; 8(4):757-770.

PMID: 38099061 PMC: 10720267. DOI: 10.1016/j.synbio.2023.11.004.

Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition.

McShan A, Flores-Solis D, Sun Y, Garfinkle S, Toor J, Young M Nat Commun. 2023; 14(1):8204.

PMID: 38081856 PMC: 10713829. DOI: 10.1038/s41467-023-43654-9.

High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform.

Bruno P, Timms R, Abdelfattah N, Leng Y, Lelis F, Wesemann D Nat Biotechnol. 2023; 41(7):980-992.

PMID: 36593401 PMC: 10314971. DOI: 10.1038/s41587-022-01566-x.

References

Hombrink P, Hassan C, Kester M, de Ru A, van Bergen C, Nijveen H . Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach. J Immunol. 2013; 190(8):3869-77. DOI: 10.4049/jimmunol.1202351. View

Koopmann J, Post M, Neefjes J, Hammerling G, Momburg F . Translocation of long peptides by transporters associated with antigen processing (TAP). Eur J Immunol. 1996; 26(8):1720-8. DOI: 10.1002/eji.1830260809. View

Hassan C, Kester M, de Ru A, Hombrink P, Drijfhout J, Nijveen H . The human leukocyte antigen-presented ligandome of B lymphocytes. Mol Cell Proteomics. 2013; 12(7):1829-43. PMC: 3708169. DOI: 10.1074/mcp.M112.024810. View

Emsley P, Lohkamp B, Scott W, Cowtan K . Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 4):486-501. PMC: 2852313. DOI: 10.1107/S0907444910007493. View

Tynan F, Burrows S, Buckle A, Clements C, Borg N, Miles J . T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol. 2005; 6(11):1114-22. DOI: 10.1038/ni1257. View

Evans P . Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr. 2005; 62(Pt 1):72-82. DOI: 10.1107/S0907444905036693. View

Liu Y, Miles J, Neller M, Gostick E, Price D, Purcell A . Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J Biol Chem. 2013; 288(22):15442-54. PMC: 3668706. DOI: 10.1074/jbc.M112.447185. View

Probst-Kepper M, Stroobant V, Kridel R, Gaugler B, Landry C, Brasseur F . An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J Exp Med. 2001; 193(10):1189-98. PMC: 2193327. DOI: 10.1084/jem.193.10.1189. View

Burrows S, Rossjohn J, McCluskey J . Have we cut ourselves too short in mapping CTL epitopes?. Trends Immunol. 2005; 27(1):11-6. DOI: 10.1016/j.it.2005.11.001. View

10.

Bell M, Burrows J, Brennan R, Miles J, Tellam J, McCluskey J . The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length. Mol Immunol. 2009; 46(8-9):1911-7. DOI: 10.1016/j.molimm.2008.12.003. View

11.

Ben Dror L, Barnea E, Beer I, Mann M, Admon A . The HLA-B*2705 peptidome. Arthritis Rheum. 2010; 62(2):420-9. DOI: 10.1002/art.27257. View

12.

Probst-Kepper M, Hecht H, Herrmann H, Janke V, Ocklenburg F, Klempnauer J . Conformational restraints and flexibility of 14-meric peptides in complex with HLA-B*3501. J Immunol. 2004; 173(9):5610-6. DOI: 10.4049/jimmunol.173.9.5610. View

13.

Ebert L, Liu Y, Clements C, Robson N, Jackson H, Markby J . A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. Cancer Res. 2009; 69(3):1046-54. DOI: 10.1158/0008-5472.CAN-08-2926. View

14.

Speir J, Stevens J, Joly E, Butcher G, Wilson I . Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. Immunity. 2001; 14(1):81-92. DOI: 10.1016/s1074-7613(01)00091-7. View

15.

Mommen G, Frese C, Meiring H, van Gaans-van den Brink J, de Jong A, van Els C . Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD). Proc Natl Acad Sci U S A. 2014; 111(12):4507-12. PMC: 3970485. DOI: 10.1073/pnas.1321458111. View

16.

Rist M, Theodossis A, Croft N, Neller M, Welland A, Chen Z . HLA peptide length preferences control CD8+ T cell responses. J Immunol. 2013; 191(2):561-71. DOI: 10.4049/jimmunol.1300292. View

17.

Scull K, Dudek N, Corbett A, Ramarathinam S, Gorasia D, Williamson N . Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands. Mol Immunol. 2012; 51(2):136-42. DOI: 10.1016/j.molimm.2012.02.117. View

18.

Tynan F, Borg N, Miles J, Beddoe T, El-Hassen D, Silins S . High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J Biol Chem. 2005; 280(25):23900-9. DOI: 10.1074/jbc.M503060200. View

19.

Adams P, Afonine P, Bunkoczi G, Chen V, Davis I, Echols N . PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 2):213-21. PMC: 2815670. DOI: 10.1107/S0907444909052925. View

20.

Gras S, Wilmann P, Chen Z, Halim H, Liu Y, Kjer-Nielsen L . A structural basis for varied αβ TCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule. J Immunol. 2011; 188(1):311-21. DOI: 10.4049/jimmunol.1102686. View